Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection.
about
Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice.Recent advances in developing vaccines against Toxoplasma gondii: an update.Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice.Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.Recent developments in nanocarrier-aided mucosal vaccination.Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination.Moving towards improved vaccines for Toxoplasma gondii.Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis.Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections
P2860
Q36156444-2C548055-7295-4571-BE79-F61705DFB45DQ38607376-EB0F0CB1-F30D-4DF2-B9D9-2B5B9D587F88Q38740356-594F1CC6-9A91-42BD-998F-597A285AEC3BQ39287046-6E17EEF2-8C40-4517-A5C3-397A908518E1Q40228907-5469341E-B76C-4D12-88F4-215E15446DFDQ40482585-0D717634-A6B0-47EC-86FF-8B3E022469F6Q40498945-458BD1AF-0C19-4E9D-B5AE-6FBE40FE55E9Q40713612-9F5C8202-3113-4802-988E-541E7918B250Q42261896-35C553CF-C9EA-4914-836B-AA5E4C025B18Q47318857-A5BA1CC6-4E1A-4896-A132-A973484D8B06Q51743228-10B99389-418B-4450-89AD-701F4D96B0F0Q55224227-39CFF7AF-E7AE-428B-AE4A-BCABDB6AECDFQ57091953-46C0364B-53FF-46C2-850A-D2684014D1FA
P2860
Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Porous nanoparticles as delive ...... c Toxoplasma gondii infection.
@en
type
label
Porous nanoparticles as delive ...... c Toxoplasma gondii infection.
@en
prefLabel
Porous nanoparticles as delive ...... c Toxoplasma gondii infection.
@en
P2093
P50
P1433
P1476
Porous nanoparticles as delive ...... c Toxoplasma gondii infection.
@en
P2093
Fatima Dahmani
Isabelle Dimier-Poisson
Thi Thanh Loi N'Guyen
P304
P356
10.1016/J.BIOMATERIALS.2015.01.056
P577
2015-02-19T00:00:00Z